Why GoodRx exists and the problem it set out to solve
GoodRx was created to address a clear market need: many people, even those with insurance, pay high prices for prescription drugs because plan copays and formulary rules do not always surface the lowest available price. The founders recognized that information about cash prices, discounts, and coupon tools was fragmented and rarely reached patients at the point of decision. By building a transparent comparison and savings platform, GoodRx aimed to empower consumers to find better prices and gain more leverage in conversations with pharmacists and prescribers.
The GoodRx founders and early impetus
GoodRx was founded by Trevor Mundel, MD, and Rajat Koodlia, who brought complementary backgrounds in technology, healthcare data, and pharmaceuticals. The idea emerged from observing how pricing opacity and complex pharmacy benefit manager (PBM) arrangements left patients overpaying for medications. The founders focused on creating a frictionless digital tool that could be used at the pharmacy counter to reveal lower cash prices and available discounts, turning price discovery into an actionable part of the prescription pickup process.
Trevor Mundel
Trevor Mundel, MD, is a neurologist and healthcare executive with deep experience in clinical development and commercial strategy. His work in data-driven healthcare solutions informed the product vision for GoodRx, emphasizing usability, transparency, and patient empowerment at the point of care.
Rajat Koodlia
Rajat Koodlia contributed technology and commercial expertise, helping to design scalable digital infrastructure and business models that could connect users, pharmacies, and advertisers in a sustainable ecosystem. Together, the pair built a service that aligned consumer savings with measurable outcomes for partner pharmacies.
How GoodRx works and core features
GoodRx operates primarily as a digital platform that compares drug prices across pharmacies and offers coupons that can lower what patients pay at the register. Its model combines price transparency with negotiated discounts, creating value for both consumers and partner networks. Key components include:
- Price comparison tools that show cash prices versus insurance copays across local pharmacies
- Digital coupons and promo codes that can be loaded to pharmacy loyalty cards or presented at checkout
- Membership options such as GoodRx Gold and GoodRx Plus that unlock higher discounts and lower copays for subscribers
- Integration with telehealth services, enabling clinicians to prescribe with price considerations in mind
Milestones and growth timeline
Since its early days, GoodRx expanded rapidly by aligning its incentives with pharmacies looking to attract price-sensitive patients. The company introduced subscription tiers, national pharmacy partnerships, and data-driven insights that strengthened its position as a trusted resource for prescription affordability. Key developments are summarized below.
| Date or Period | Event | Why It Matters |
|---|---|---|
| 2015 | GoodRx publicly launches its price comparison and coupon platform | Establishes a clear value proposition for consumers and pharmacies |
| 2017–2018 | Rapid user growth and national pharmacy network integrations | Enables broader reach and deeper price data coverage across the U.S. |
| 2020 | Introduces GoodRx Gold and telehealth connections | Differentiates offerings and aligns with shifting consumer expectations |
| 2021 | Goes public via IPO | Marks a major corporate milestone and capital raise for expansion |
| 2023 | Partnership with major pharmacy chains and expansion of discount depth | Strengthens network effects and reinforces trust with users |
Business model and revenue sources
GoodRx generates revenue through a combination of subscription fees, advertising, and performance-based arrangements with pharmacies and related stakeholders. The platform monetizes user engagement via paid memberships and by facilitating connections between pharmacies and motivated patients. Advertisers and pharmacy partners pay to feature prominently in search results and promotional placements, creating a scalable model that does not rely on selling personal health information.
Relationship with pharmacies and impact on prescription pricing
Rather than acting solely as a comparison tool, GoodRx collaborates with pharmacies to drive foot traffic and fill rates in exchange for prominent placement and access to discounts. This relationship has raised questions about potential conflicts of interest and net price transparency, which the founders and company have addressed through clearer disclosures and enhanced data reporting. The result is a marketplace where patients can more easily see and leverage lower prices while pharmacies gain a predictable stream of patients.
Current status and long-term positioning
As of the most recent full year data, GoodRx reports millions of active users and hundreds of millions in annual revenue, reflecting sustained demand for prescription affordability tools. The founders have shifted focus toward deeper integration with telehealth, chronic condition management, and value-based care partnerships. Analysts note that while competitive pressures exist, GoodRx’s brand recognition, pharmacy network scale, and diversified revenue streams support a durable long-term position in the category.
Key facts at a glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Founders | Trevor Mundel, MD, and Rajat Koodlia | Company registration and leadership bios |
| Year founded | 2015 | Public filings and corporate history |
| IPO year | 2021 | SEC filings and market data |
| Annual revenue (latest reported) | Reported in hundreds of millions of dollars | Company earnings releases |
| Active users | Multiple millions across U.S. | Company updates and analyst reports |
FAQ
Reader questions
Who were the original founders of GoodRx?
The original founders are Trevor Mundel, MD, and Rajat Koodlia. They brought clinical, technology, and commercial expertise to address prescription price transparency and affordability.
How do the founders make money with GoodRx?
Revenue streams include subscriptions, pharmacy fees for performance-driven promotions, advertising, and data partnerships. The model is designed to scale without compromising user trust.
Is GoodRx still relevant after going public?
Yes. Going public provided capital for product expansion, deeper pharmacy integrations, and investments in telehealth. Continued user growth and partnerships demonstrate ongoing relevance.
How do the founders address conflicts of interest
GoodRx has implemented clearer disclosures, data reporting standards, and governance practices to balance commercial relationships with the obligation to present fair and transparent pricing information.
What are the primary risks for the business
Key risks include regulatory changes around prescription pricing, competition from other transparency tools, and evolving payer policies that could affect coupon value and network participation.